Edgar Filing: bluebird bio, Inc.

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

2. Issuer Name and Ticker or Trading Symbol
bluebird bio, Inc. [BLUE]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O TVM CAPITAL GROUP, MAXIMILIANSTRASSE 35C

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2013

(Street)

MUNICH, 2M 80539

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2013		C		2,254,357 ⁽¹⁾	A	⁽¹⁾	2,254,357	D ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Series A-1 Convertible Preferred Stock

⁽³⁾

06/24/2013

6,169,117

⁽³⁾

Common Stock

325,255

$ 0

D ⁽²⁾

Series A-2 Convertible Preferred Stock

⁽³⁾

06/24/2013

11,835,834

⁽³⁾

Common Stock

624,021

$ 0

D ⁽²⁾

Series B Convertible Preferred Stock

⁽³⁾

06/24/2013

17,749,014

⁽³⁾

Common Stock

935,783

$ 0

D ⁽²⁾

Series C Convertible Preferred Stock

⁽³⁾

06/24/2013

3,994,248

⁽³⁾

Common Stock

210,589

$ 0

D ⁽²⁾

Series D Convertible Preferred Stock

⁽³⁾

06/24/2013

3,010,234

⁽³⁾

Common Stock

158,709

$ 0

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

660,982

⁽⁴⁾

11/16/2015

Series A-1 Convertible Preferred Stock

660,982

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

34,849

⁽⁴⁾

11/16/2015

Common Stock

34,849

$ 0

34,849

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

440,650

⁽⁴⁾

10/26/2016

Series A-1 Convertible Preferred Stock

440,650

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

23,232

⁽⁴⁾

10/26/2016

Common Stock

23,232

$ 0

23,232

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

1,038,674

⁽⁴⁾

05/03/2017

Series A-1 Convertible Preferred Stock

1,038,674

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

54,760

⁽⁴⁾

05/03/2017

Common Stock

54,760

$ 0

54,760

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

236,062

⁽⁴⁾

08/28/2018

Series A-1 Convertible Preferred Stock

236,062

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

12,445

⁽⁴⁾

08/28/2018

Common Stock

12,445

$ 0

12,445

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

236,062

⁽⁴⁾

12/18/2018

Series A-1 Convertible Preferred Stock

236,062

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

12,445

⁽⁴⁾

12/18/2018

Common Stock

12,445

$ 0

12,445

D ⁽²⁾

Series A-1 Warrants

$ 0.6619

06/24/2013

J⁽⁵⁾

462,681

⁽⁴⁾

04/15/2019

Series A-1 Convertible Preferred Stock

462,681

$ 0

D ⁽²⁾

Common Stock Warrants

$ 12.55

06/24/2013

J⁽⁵⁾

24,393

⁽⁴⁾

04/15/2019

Common Stock

24,393

$ 0

24,393

D ⁽²⁾

Series B Warrants

$ 0.3262

06/24/2013

J⁽⁶⁾

287,400

⁽⁴⁾

04/15/2019

Series B-1 Convertible Preferred Stock

287,400

$ 0

D ⁽²⁾

Common Stock Warrants

$ 6.19

06/24/2013

J⁽⁶⁾

15,152

⁽⁴⁾

04/15/2019

Common Stock

15,152

$ 0

15,152

D ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
TVM V LIFE SCIENCE VENTURES GMBH & CO KG C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
TVM Capital GmbH C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
Polack Axel C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
SCHUHSLER HELMUT C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
Goll Alexandra C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
Birner Hubert C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X
Fischer Stefan C/O TVM CAPITAL GROUP MAXIMILIANSTRASSE 35C MUNICH, 2M 80539		X

Signatures

/s/ Stefan Fischer, Attorney-in-Fact for TVM V Life Science Ventures GmbH & Co. KG		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer, Attorney-in-Fact for TVM Capital GmbH		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer, Attorney-in-Fact for Axel Polack		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer, Attorney-in-Fact for Helmut Schuehsler		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer, Attorney-in-Fact for Alexandra Goll		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer, Attorney-in-Fact for Hubert Birner		06/24/2013
^**Signature of Reporting Person		Date
/s/ Stefan Fischer		06/24/2013
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This transaction represents the total number of shares received upon conversion of bluebird bio, Inc. ("bluebird") Series A-1 Convertible Preferred Stock ("Series A-1 Shares"), Series A-2 Convertible Preferred Stock ("Series A-2 Shares"), Series B Convertible Preferred Stock ("Series B Shares"), Series C Convertible Preferred Stock ("Series C Shares") and Series D Convertible Preferred Stock (the "Series D Shares" and together with the Series A-1 Shares, Series A-2 Shares, Series B Shares and Series C Shares, collectively, the "Preferred Shares").
(2)	The shares are held directly by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"). TVM V's general partner, TVM Capital GmbH ("TVM"), and its authorized officers, Axel Polack ("Polack"), Helmut Schuehsler ("Schuehsler"), Alexandra Goll ("Goll"), Hubert Birner ("Birner") and Stefan Fischer ("Fischer") may be deemed to share voting and dispositive power over the shares held by TVM V. Each of TVM, Polack, Schuehsler, Goll, Birner and Fischer disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
(3)	The Preferred Shares automatically converted into bluebird Common Stock on an 18.967-for-one ratio upon the closing of the initial public offering of bluebird without payment of further consideration. The Preferred Shares had no expiration date.
(4)	The warrants are currently exercisable.
(5)	This transaction represents a deemed disposition of warrants to purchase shares of Series A-1 Convertible Preferred Stock and a deemed acquisition of warrants to purchase shares of Common Stock on an 18.967-for-one basis, which happened automatically upon the closing of the initial public offering of bluebird without payment of further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.
(6)	This transaction represents a deemed disposition of warrants to purchase shares of Series B Convertible Preferred Stock and a deemed acquisition of warrants to purchase shares of Common Stock on an 18.967-for-one basis, which happened automatically upon the closing of the initial public offering of bluebird without payment of further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.